Filing Details
- Accession Number:
- 0001104659-22-124078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-02 16:00:39
- Reporting Period:
- 2022-12-01
- Accepted Time:
- 2022-12-02 16:00:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711933 | Akoya Biosciences Inc. | AKYA | Laboratory Analytical Instruments (3826) | 475586242 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1857405 | Ph.d. Garry Nolan | 100 Campus Drive, 6Th Floor Marlborough MA 01762 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-01 | 5,000 | $13.36 | 593,078 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $13.25 and $13.50, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
Billionaire Hedge Funds
